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Photobiomodulation of human 
dermal fibroblasts in vitro: decisive 
role of cell culture conditions 
and treatment protocols on 
experimental outcome
C. Mignon1,2, N. E. Uzunbajakava1, B. Raafs1, N. V. Botchkareva2 & D. J. Tobin  2
Photobiomodulation-based (LLLT) therapies show tantalizing promise for treatment of skin diseases. 
Confidence in this approach is blighted however by lamentable inconsistency in published experimental 
designs, and so complicates interpretation. Here we interrogate the appropriateness of a range 
of previously-reported treatment parameters, including light wavelength, irradiance and radiant 
exposure, as well as cell culture conditions (e.g., serum concentration, cell confluency, medium 
refreshment, direct/indirect treatment, oxygen concentration, etc.), in primary cultures of normal 
human dermal fibroblasts exposed to visible and near infra-red (NIR) light. Apart from irradiance, all 
study parameters impacted significantly on fibroblast metabolic activity. Moreover, when cells were 
grown at atmospheric O2 levels (i.e. 20%) short wavelength light inhibited cell metabolism, while 
negligible effects were seen with long visible and NIR wavelength. By contrast, NIR stimulated cells 
when exposed to dermal tissue oxygen levels (approx. 2%). The impact of culture conditions was 
further seen when inhibitory effects of short wavelength light were reduced with increasing serum 
concentration and cell confluency. We conclude that a significant source of problematic interpretations 
in photobiomodulation reports derives from poor optimization of study design. Further development 
of this field using in vitro/ex vivo models should embrace significant standardization of study design, 
ideally within a design-of-experiment setting.
Photobiomodulation (PBM) or low-level light therapy (LLLT)1 is a rapidly expanding field, showing encouraging 
results for treatment of cutaneous disorders2, 3 and a wider range of health conditions4–6.
In dermatology, application of PBM spans the cosmetic and medical fields including androgenetic alopecia7, 
8, alopecia areata9, skin rejuvenation10, wound healing11 and alleviation of psoriasis vulgaris and atopic dermatitis 
symptoms12, 13, where many commercialized professional and home-use devices exist3, 14.
Therapeutic action of PBM is attributed to non-thermal photochemical or photobiological action of light 
via interaction with a range of endogenous photoreceptors and chromophores contained in human skin3, 15, 16. 
Photoreceptors and mediators of the photobiological action of visible and NIR light include cytochrome c oxi-
dase, nitrosated and flavo- proteins, opsins and ion-gated channels3, 17–19. Meanwhile, investigations on potential 
action mechanisms of PBM using in vitro and ex vivo models continue, but often reporting very contradictory 
results2, 7, 20, 21.
A remarkably wide range of optical parameters has been applied to both in vitro and ex vivo model systems 
(variable across 2 orders of magnitude), where negative, positive and neutral outcomes are reported for visible 
and near-infrared (NIR) light despite very similar optical settings3, 8, 9, 11. For example, exposure of human epi-
dermal keratinocytes to similar doses of short wavelength visible light (i.e., 420 and 450 nm) were reported to 
alternately induce and reduce expression of differentiation markers20, 22.
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Clarity on how one particular optical setting truly impacts on cell behavior is further compromised in pub-
lished reports that don’t even disclose parameters applied or if they do sadly report them incorrectly3.
It now appears clear that gene expression patterns can be influenced in a dynamic time-varying manner by a 
single light treatment of defined parameters further suggesting that experimental outcomes are tightly coupled 
to treatment regime23.
Previously we have demonstrated that variations in treatment protocol and cell culture conditions result in 
different outcomes despite using the same light parameter24. In particular, interaction between components of 
cell culture medium and blue light (450 nm) can lead to cytotoxicity in human dermal fibroblasts when irradiated 
in the DMEM culture medium, but that this effect can be prevented by medium refreshment directly after light 
treatment24.
Therefore, we hypothesized that in vitro cell response to light is not exclusively defined by optical parameters 
and regimes, but rather also depends on treatment protocols. Variations in the latter may account for the myriad 
inconsistencies in the PBM literature3.
A number of factors can potentially affect PBM experimental outcomes such as cell confluency, passage, 
donor, donor age, body site, as well as differences in gene expression programs between primary cells and cell 
lines and many others even more difficult to apprehend such as the lack of standardization of the composi-
tion of bioactive compounds in FBS batch25, 26. Additional factors will also involve the biological diversity of 
any one histologically-distinct cell type e.g., different subtypes of skin dermal fibroblast (DF)27, 28 including the 
highly proliferative and low metabolically active papillary, and the less proliferative, more metabolically active 
reticular dermal fibroblasts29 and other cutaneous fibroblast subpopulations such as dermal sheath and dermal 
papilla fibroblasts of the hair follicle29 with strikingly different morphology, metabolism and gene expression. It is 
expected that these different cutaneous fibroblast subtypes will respond differently to light30, 31.
Therefore robust assessment of the therapeutic value of PBM requires multidimensional investigations, where 
optical (wavelength, radiant exposure, irradiance) and biological factors (cell type, subtype), as well as treatment 
protocols (environment of the cells during culture and treatment, supplements/components in growth medium, 
treatment iteration etc.) all need to be evaluated.
The aim of this study was to investigate the impact of several key factors such as wavelength, irradiance, radi-
ant exposure, serum concentration, cell culture confluency, environmental oxygen concentration, light-based 
treatment regime and cell culture protocols on the response to light of human dermal fibroblasts in vitro.
Results
Impact of optical parameters on the response of human dermal fibroblasts to light treat-
ment. Accordingly to a body of research on PBM, the wavelength of light and the radiant exposure exert the 
most profound effect on cell response to optical radiation, moreover reports indicating importance of irradiance 
in defining cell behavior upon irradiation can also be found in literature2, 32. Indeed, our results demonstrate that 
wavelength (p < 0.001) and radiant exposure (p < 0.001) of light had the strongest impact on the metabolic activ-
ity of human DF. At the same time, irradiance showed no or little effect (p = 0.6) (Fig. 1A–C). We observed that, 
on average, shorter wavelengths (450, 500 and 530 nm) have a large impact on fibroblast metabolic activity, while 
long wavelengths (>550 nm) show negligible effects within the tested radiant exposures when cells were cultured 
at 20% environmental oxygen (atmospheric level).
Wavelength and radiant exposure of light were strongly linked (Fig. 2A p < 0.001), whereby a radiant 
exposure-dependent cell behavior was seen with the short visible wavelengths (<550 nm). Low light exposure 
(2 J.cm−2) exhibited essentially neutral effects on fibroblast metabolic activity at all wavelengths, while cell inhib-
itory effects were seen at high exposures of light at 450, 500 and 530 nm (Fig. 2).
By contrast, no interaction was observed between irradiance levels and any of the optical factors (i.e. wave-
length and radiant exposure, Fig. 2B,C) in terms of cell metabolic activity, specifically meaning that a choice of 
irradiance at a fixed dose and a wavelength did not impact cell response.
Impact of biological factors on the response of human dermal fibroblasts to light treat-
ment. To assess the impact of several biological factors on the response of DFs to light we selected a single 
wavelength (450 nm) as it exerted the strongest effect on the relative metabolic activity of the target cells, and 
varied radiant exposure from 2 J.cm−2 to high 60 J.cm−2 (Fig. 1D–F).
Fibroblast confluency and serum concentration strongly influence how specific light parameters affect cell 
behavior (Fig. 1D,E). In particular, lower cell confluency or lower serum concentration resulted in stronger 
light-associated inhibition of cell metabolic activity (Fig. 2D,E). Both lineages of fibroblasts (i.e., reticular and 
papillary) responded similarly to test light parameters (Fig. 1F).
As expected, serum concentration and confluency were related. High serum concentrations drove higher 
fibroblast proliferation and so confluency, given equal initial seeding density (Fig. 3, A B control bars).
In order to isolate the effect of serum concentration alone on the impact of light treatment, cells both at low 
and high confluency were treated using the same light parameter and protocol at the two culture conditions, 2% 
FBS and 10% FBS. At 60 J.cm−2 (Fig. 3B) the reduction of the metabolic activity of the fibroblasts grown in low 
serum was much stronger than at high serum, (60% versus 40%, respectively). This effect was also reflected in 
changes in cell morphology. Light treatment (450 nm, 60 J.cm−2) in low serum and low confluency fibroblasts 
triggered cytotoxic effects (Fig. 3A), while cells in high serum and low confluency (Fig. 3A) and in combinations 
of high confluency/low serum and high confluency/high serum (data not shown) exhibited no cytotoxic effects.
To further investigate the effect of defined light parameters on DF metabolic activity, experiments were car-
ried out at two different cell confluency levels: low (20%, 5,000 cells per 1.77 cm2 well area at seeding) and a very 
high (90%, 30,000 cells per 1.77 cm2 well area at seeding) (Fig. 4A). Remarkably, the same light parameter applied 
to what is typically assumed in the PBM literature as ‘identical’ cells, albeit at different confluencies, resulted in 
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opposite effects (Fig. 4B). This was clearly different at two dose levels used, i.e., 2 and 30 J.cm−2 (only the higher 
dose is shown). It appears that DF at high confluencies (>90%) may be more ‘protected’ in response to 450 nm 
light, at least in context of metabolic activity.
Impact of the treatment regimes and protocols on dermal fibroblast metabolic activity. The 
choice of treatment regime, in particular, the number of consecutive treatments, impacts on the cell response to 
light, reflected in both cell metabolic activity and cell morphology. More specifically, a single exposure to 2 J.cm−2 
and 30 J.cm−2 of 450 nm light resulted in an increase in metabolic activity, while 2, 3 or 4 consecutive treatments 
(Fig. 5B) reversed the effect, leading to decrease in cell metabolism.
Observed changes in metabolic activity were accompanied by morphological alterations (Fig. 5A), such 
as shrinkage of cells, which became more pronounced with an increase in the number of exposures. After 4 
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Figure 1. Main effects plot of the wavelength, radiant exposure, irradiance, serum concentration, initial cell 
confluency and lineage on the relative metabolic activity of fibroblasts. Main effects plot of the wavelength 
(A), radiant exposure (B) and irradiance (C) on the relative metabolic activity of human dermal fibroblasts 
(reticular and papillary). Data points correspond to grand means, i.e. the average value of the metabolic activity 
for each level of one selected factor (wavelength, dose or irradiance) while all the levels of the two other factors 
are averaged. Statistical significance was evaluated using ANOVA (N = 3, 2 lineages and 3 replicates). The 
levels of radiant exposure correspond to 2 J.cm−2 (low) and 30 J.cm−2 (high), the levels of irradiance depended 
on wavelength and are reported in Table 1 in the Materials and Methods Section. Main effects plot of serum 
concentration (D), initial confluency (E) and lineage (F) on the relative response of the metabolic activity 
of human dermal fibroblasts after light treatment (450 nm, 2 to 60 J.cm−2). Data points correspond to grand 
means, i.e. the average value of the metabolic activity for each level of one selected factor (serum concentration, 
confluency, lineage) while all the levels of the two other factors are averaged. Statistical significance was 
evaluated using ANOVA (N = 2, 2 lineages and 3 replicates). The initial ratio at the moment of seeding between 
‘high’ and ‘low’ confluency groups is 5. The control group is has an average relative metabolic activity of 1.
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treatments, cells were significantly smaller than the corresponding control cells. This observed steady shrinking 
of cell volume could reflect the observed decrease in cell metabolic activity. A similar effect was also present in 
cells grown at low confluency (Fig. 4A).
Reducing light treatment frequency, from daily, every 24 hours, to every other day, every 48 hours, did not 
change the observed drop in metabolic activity or effect of cell morphology (Fig. 5B), suggesting that the initial 
exposure triggers a chain of molecular reactions lasting longer than 24 hours.
Secondly, the treatment protocol used, in particular the culture medium components exerted a significant 
impact on the outcome of the light exposure to short visible wavelengths (Fig. 6A).
Previously, we have shown that exposure of DF to blue light of 450 nm (30 J.cm−2) in culture media (DMEM), 
without its subsequent refreshment, resulted in cytotoxic effects 24 hours after treatment. Here we observed a sim-
ilar effect at the wavelength up to 530 nm, suggesting that a wide range of short visible wavelengths are absorbed 
by components of the cell culture media, leading to generation of molecules further impacting cell physiology.
We next assessed whether this effect was dependent on cell-free elements of the culture conditions, and found 
that DF exposure to cell-free media, irradiated using 30 J.cm−2 and 60 J.cm−2, resulted in reduced metabolic activ-
ity of the cells. The magnitude of this affect however, was lower than when cells in culture were directed irradiated 
(Fig. 6B), though fibroblast morphology was impaired only at 60 J.cm−2 (Fig. 6C).
Impact of the oxygen level in cell culture medium on cellular response to light. Recent evidence 
suggests the existence of gradients of physiological oxygen levels throughout the different layers of human skin 
layers, where oxygen level in dermis (outside capillary loops) can be as low as 1–5%, compared to 20% atmos-
pheric level33, 34. We therefore studied the effects of lowering oxygen concentration from 20% to 2% in our fibro-
blast cultures; i.e., to a physiologically-relevant concentration of oxygen in terms of DF interaction with visible 
light in vivo.
The reduction from 20% to 2% oxygen concentration did not result in noticeable changes in the metabolic 
activity or morphology in control fibroblast (papillary and reticular) cultures, (Fig. 7A).
By contrast, lowering oxygen concentration resulted in dramatic differences in fibroblast response to light. In 
particular, blue light (450 nm) at 30 J.cm−2 resulted in even stronger inhibition of metabolic activity of papillary 
fibroblasts than when grown in 20% oxygen. Remarkably, NIR light (850 nm) at 20 J.cm−2 stimulated metabolic 
activity of human reticular fibroblasts at physiological levels of oxygen (i.e. 2%), the effect that was not observed 
at 20% oxygen level. These effects were not associated with any significant change on the relative cell number 
(Fig. 7B).
Discussion and Conclusions
The goal of this study was to investigate the impact of optical parameters, cell culture protocols and treatment 
regimes on the metabolic activity of primary human dermal fibroblasts in vitro culture in response to visible and 
near-infrared radiation.
To achieve this we systematically studied the impact of wavelength, irradiance, dose, number of consecutive 
irradiations, serum- and oxygen concentration, cell confluency, medium refreshment and indirect treatment with 
irradiated medium alone in a design-of-experiment approach. The latter was specifically chosen in order to dis-
entangle the effects caused by a direct interaction of photons of light with cells from the potential contribution of 
multiple ‘environmental’ factors.
We also aimed to explore whether the response of DF to identical optical parameters would change when 
cultured at conditions that more closely resemble those in vivo, i.e. low proliferation, cell confluency, serum and 
oxygen levels, as we felt that this is crucial when considering application of new technologies to in vivo clinical 
settings.
Several interesting and unexpected findings resulted from the approach, new to the world of photobiomodu-
lation, which cause us to step back and re-assess how we interpret PBM data derived from in vitro studies.
Parameter
Wavelength 
(nm)
Irradiance 
(mW.cm−2)
Radiant 
exposure 
(J.cm−2) Parameter
Wavelength 
(nm)
Irradiance 
(mW.cm−2)
Radiant 
exposure 
(J.cm−2)
Blue-Low-Low 450 10 2 Yellow-Low-Low 590 3 2
Blue-Low-High 450 10 30 Yellow-Low-High 590 3 10
Blue-High-Low 450 50 2 Yellow-High-Low 590 7 2
Blue-High-High 450 50 30 Yellow-High-High 590 7 10
Cyan-Low-Low 500 10 2 Red-Low-Low 655 10 2
Cyan-Low-High 500 10 30 Red-Low-High 655 10 30
Cyan-High-Low 500 40 2 Red-High-Low 655 65 2
Cyan-High-High 500 40 30 Red-High-High 655 65 30
Green-Low-Low 530 10 2 IR-Low-Low 850 10 2
Green-Low-High 530 10 30 IR-Low-High 850 10 30
Green-High-Low 530 30 2 IR-High-Low 850 80 2
Green -High-High 530 30 30 IR-High-High 850 80 30
Table 1. Light parameters used for treatment of human dermal fibroblasts following a factorial design of 
experiment.
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First, all investigated parameters in this study, with the exception of irradiance, significantly impacted skin 
fibroblast metabolic responses to light.
Secondly, cell culture and treatment conditions (including confluency, serum- and environmental oxygen 
concentrations and treatment protocols) all significantly influence cellular responses to optical radiation, even 
when the identical wavelength, irradiance and dose were applied.
While medium-to-high confluency scenario is convention cell culture practice worldwide, in vivo DF are 
sparsely distributed throughout papillary and reticular dermal compartments. In an attempt to observe cells in 
a more natural situation, cultured at low confluency, we noticed that three consecutive daily treatments using 
short-wavelength visible light (450 nm at 30 J.cm−2) reduced their metabolic activity to a greater extent than when 
maintained at medium-to-high confluency.
Similarly, we observed that DF grown in lower FBS concentration 2%, though still higher than a fibroblast in 
a non-wounded skin environment would experience, coped less efficiently with induced stress, and were more 
inhibited by several consecutive exposures to 450 nm light at 30 J.cm−2. This response was clearly different from 
that of fibroblasts cultured at 10% FBS who were less inhibited and even protected from light-associated reactive 
oxygen species (ROS), as evidenced by normal metabolic activity and morphology. Similarly to low confluency, 
lower serum exposure may be more physiologically relevant.
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Figure 2. Interactions plot between the wavelength, radiant exposure, irradiance, cell confluency and serum 
concentration and their relative impact on human dermal fibroblasts metabolic activity. Interactions between 
wavelength and radiant exposure (A), irradiance and radiant exposure (B) and irradiance and wavelength (C) 
and their relative impact on human dermal fibroblasts metabolic activity (reticular and papillary). Data points 
correspond to grand means, i.e. the average value of the metabolic activity for each level of two selected factors 
(wavelength and radiant exposure, radiant exposure and irradiance or wavelength and irradiance) while all 
the levels of the remaining factor are averaged. Statistical significance was evaluated using ANOVA (N = 3, 2 
lineages and 3 replicates). The levels of radiant exposure correspond to 2 J.cm−2 (low) and 30 J.cm−2 (high), 
the levels of irradiance depended on wavelength and are reported in Table 1 in the Materials and Methods 
Section. Interactions between levels of radiant exposure of 450 nm light and serum concentration (D), and 
initial confluency (E) and their impact on the relative response of the metabolic activity of human dermal 
fibroblasts. Data points correspond to grand means, i.e. the average value of the metabolic activity for each level 
of two selected factors (radiant exposure and serum concentration or radiant exposure and confluency) while 
all the levels of the remaining factor are averaged. Statistical significance was evaluated using ANOVA (N = 2, 2 
lineages and 3 replicates). The initial ratio at the moment of seeing between ‘high’ and ‘low’ confluency groups is 
5. The control group has an average relative metabolic activity of 1.
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The latter two findings may suggest that ‘non-physiological’ highly confluent cell cultures of DF in 10% FBS 
may be ‘more protected’ from potential stressors induced by light, such as ROS35, 36, than the cells in vivo. Two 
factors could potentially play a role here. First factor is a lower proliferative activity and thus lower number of 
mitotic cells (known to be more vulnerable to noxious factors37, 38 of highly confluent cell cultures of DF. Secondly, 
we also hypothesize that the higher the number of cells exposed to the light treatment event the stronger the anti-
oxidant defense may be against any ROS created by irradiation of the cell medium constituents, as the latter was 
kept constant in all experiments regarding of cell number per well.
In addition to cell confluency and serum concentration, we assessed whether continuing to expose fibroblasts 
to their irradiated medium post-treatment negatively impacted on their viability. Specifically, we have shown that 
high radiant exposures of short visible wavelengths (450 and 500 nm, at 30 and 60 J.cm−2) suppressed fibroblast 
metabolic activity, and even resulted in some cytotoxicity when the medium was not refreshed after irradiation. 
Importantly, irradiation of cell-free culture medium that was then exposed to the cells resulted in an inhibi-
tory effect, suggesting that ROS released after light absorption by riboflavin known to be present in the culture 
medium may have been at least in part responsible for this observed inhibitory effect. Previously it was shown 
Figure 3. Serum concentration in the culture medium reduces the inhibitory effect of blue light (450 nm) on 
the metabolic activity of human dermal fibroblasts. (A) Phase-contrast images of human reticular fibroblasts 
on day 0 (8 days after seeding) at low initial confluency and cultured in DMEM with two serum concentrations 
2% and 10% (upper line), and after three daily light treatments on day 4 at a low initial confluency (lower line). 
Papillary fibroblasts were found to behave similarly (not shown). A second donor responded similarly (not 
shown). (B) Relative metabolic activity of human reticular fibroblasts after light treatment at 450 nm, 50 mW.
cm−2 with 60 J.cm−2 (log scale). We observe a 60% reduction in 2% FBS against 40% reduction in 10% FBS 
case compared to control. The high confluency level showed similar variation as a function of the change in 
FBS concentration (not shown), except for the cytotoxic effects observed in low serum/low confluency only. 
Statistical significance was evaluated using ANOVA. A second donor responded similarly (not shown as the 
scale is absolute). The control group has an average relative metabolic activity of 1. (N = 2, 2 lineages and 3 
replicates).
www.nature.com/scientificreports/
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that riboflavin mediated cytotoxic effects in human skin melanoma cells after irradiation by blue light (470 nm)39. 
However, it may not be completely artefactual, as it is also known that flavins are present in normal human skin 
dermis40 where they are likely to respond to clinical PBM modalities. However, we observed greater effects with 
the irradiated cell plus medium combination (than with the irradiated medium treatment alone), suggesting that 
there is a distinct cellular–derived component to the light response, indicating that photons of visible light can 
indeed directly interact with DF cells. Previously, interesting effects were observed in cells irradiated by ionizing 
radiation where oxidative stress was transferred from the irradiated cell to non-irradiated cells, via the release 
of components in the medium and even via the irradiated supernatant alone, which received a name ‘bystander 
effect’41, 42. Several signaling molecules mediated the transfer of oxidative stress. Small molecules, such as Ca2+ or 
peptides, were transmitted via gap junction intercellular communication to neighboring cells. Larger molecules, 
which could also be released by the irradiated cells, could propagate the damage and include lipid peroxide prod-
ucts and cytokines and reach neighboring cells by diffusion43, 44.
Next to cell culture conditions, what is less clear in PBM literature is if and how the experimental outcome 
depends on a number of consecutive treatments. Our observation is that the effect of shorter wavelengths 
(450 nm–590 nm) is accumulated over increasing number of consecutive daily and every other day treatments, 
suggests that the light can have prolonged effects on dermal fibroblasts, beyond cessation of irradiation, via the 
initiation of downstream cascade of cell signaling.
Figure 4. An increase in the cell confluency of human dermal fibroblasts reduces the inhibitory effect of blue 
light (450 nm) on their metabolic activity. (A) Phase-contrast images of human papillary fibroblasts on day 0 
(8 days after seeding) at a low initial confluency (upper left) and high initial confluency (upper right), and after 
three light treatments on day 4 at a low initial confluency (lower left) and high initial confluency (lower right). 
Reticular fibroblasts were found to behave similarly (not shown). (B) Relative metabolic activity of human 
papillary fibroblasts after light treatment at 450 nm, 50 mW.cm−2 with 30 J.cm−2 in function of the confluency 
level. Statistical analysis was evaluated using student t-tests between the control group and the treated group 
(N = 3, 2 lineages and 3 replicates), with following thresholds *p < 0.05, **p < 0.01, ***p < 0.001. The control 
group has an average relative metabolic activity of 1. The significance of the interaction between the radiant 
exposure and the confluency level was much lower than 0.001.
www.nature.com/scientificreports/
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A key finding of our study was the observation that oxygen concentration markedly impacted on the response 
of dermal fibroblasts to both short visible- and to near-infrared light. Lowering oxygen to physiological level (i.e. 
2%) resulted in fibroblast stimulation by near-infrared wavelengths: an observation not seen when cells were 
exposed to conventional cell culture oxygen levels (i.e. 20%), and so our protocol may allow researchers to appro-
priately investigate the photobiomodulation effects on skin and hair health. Indeed, researchers have shown the 
importance of environmental oxygen concentration at the genomic and proteomic levels in cells from various 
body locations. Physiological levels of oxygen in the body are organ-dependent and generally different from the 
standard oxygen concentration not only in human skin compartments but also in brain, lungs, liver and other 
body organs45. This therefore raises the need to distinguish between ‘normoxia’ and ‘physioxia’, and how this could 
impact PBM studies conducted using in vitro cell culture.
Skin temperature in itself could represent another condition to optimize in the pursuit of in vivo approxima-
tion. In the case of skin, the temperature is commonly assumed to be around 34 °C45. However, finding the right 
skin temperature might be complex for at least two reasons. First, there is evidence showing that skin temperature 
is highly variable within the body and dependent on the ambient temperature46. Second, related to light treatment 
in vivo, there will be thermal effects involved due to the strong optical absorption of visible and NIR radiations by 
skin chromophores (melanin, blood).
Figure 5. Response of human dermal fibroblasts to variable number of treatments with blue light (450 nm) 
occurring on consecutive days. (A) Phase-contrast images of human reticular fibroblasts 24 h after the last 
treatment, when 1, 2, 3 or 4 daily treatments (30 J.cm−2) were performed (lower line), together with the images 
of the control group (upper line). (B) Relative metabolic activity of human papillary and reticular fibroblasts 
(merged) after light treatment for 2 radiant exposures of 450 nm light (at a fixed 50 mW.cm−2 irradiance) and 
with variable number of treatments occurring on consecutive days. An irradiance of 50 mW.cm−2 was used. 
Statistical analysis was evaluated using student t-tests between the control group and treated group (N = 2, 2 
lineages and 3 replicates), with following thresholds *p < 0.05, **p < 0.01, ***p < 0.001. The control group has 
an average relative metabolic activity of 1. The significance of the interaction between the radiant exposure and 
the number of iterative treatment was much lower than 0.001.
www.nature.com/scientificreports/
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Similarly, our data suggests that in vitro protocols may be more physiological if irradiation is done with cells 
in culture medium rather than in a buffer such as PBS, given that in vivo (both steady state and during wounding/
wound-healing) interstitial fluids and extracellular matrix will contain a complex mixture of essential minerals, 
ions, growth factors, and other nutrients and ligands’, which likely contribute to the total cellular response to light. 
However, the lack of in vivo ‘flow’ conditions in our static in vitro setup suggests that refreshment of medium after 
light treatment may be advisable. The downside being the loss of important autocrine cytokines and growth fac-
tors. In particular, we know that it may be important in the context of photobiomodulation, where latent growth 
factors have been shown to be activatable via infrared radiation4.
Interestingly, some of our study findings differ from those previously reported in the literature. First, our 
results did not show any strong effect of long visible and NIR radiation under environmental partial oxygen 
pressure. This observation is not surprising by itself, as the literature contains large discrepancies between the 
optical parameters and experimental outcomes used hitherto, impeding progress of PBM modality as previ-
ously reported3. More specifically, the majority of previous studies showed a measurable effect of red and NIR 
wavelengths in vitro and on ex vivo systems4–6, 19, 47. Other studies, however, found no effect of long visible and 
NIR wavelengths on skin cells20, 48. While not excluding the impact of cell culture conditions and oxygen levels 
on these, often opposite, experimental outcomes, we still hypothesize that human dermal fibroblasts, positioned 
Figure 6. The inhibitory effect of blue light (450 nm) on the metabolic activity of human dermal fibroblasts is 
mediated by components present in the culture medium. (A) Relative metabolic activity of fibroblasts after light 
treatment as a function of the wavelength and the treatment regime (one or more consecutive irradiations) and 
protocol (direct light exposure or contact with pre-exposed culture medium). Metabolic activity after treatment 
was normalized to that of the control sample. Number of donors N = 3, number of technical replicates n = 3, data 
on papillary and reticular pools were merged together. The significance of the interaction between wavelength 
and treatment method was evaluated with ANOVA (p ≪ 0.001). (B) Relative metabolic activity of the fibroblasts 
after light treatment for two treatment protocols: direct light exposure (blue) and pre-exposure of DMEM 
alone followed by pouring on top of the cells (cyan). (C) Phase-contrast pictures of human reticular fibroblasts 
24 h after the last treatment, in control group, treated group (30 J.cm−2 and 60 J.cm−2) and treated by irradiated 
cell-free media. An irradiance of 50 mW.cm−2 was used. Statistical analysis was evaluated using student t-tests 
between the control group and treated group (N = 3, reticular and 3 replicates), with following thresholds 
*p < 0.05, **p < 0.01, ***p < 0.001. The control group is has an average relative metabolic activity of 1.
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deeper than epidermal melanocytes and keratinocytes, are more shielded from the blue part of the electromag-
netic spectrum but are much more exposed to red and NIR components, and therefore could have adapted to 
them. Consequently one could suspect a stronger resistance of dermal fibroblasts to visible and NIR radiation, 
particularly in the long wavelength range, due to evolutionary reasons. The same reasoning may suggest that 
fibroblast originating from more deeply located tissues are more sensitive to light photons.
Second, we did not spot any irradiance effect in vitro despite some existing evidence in the literature both for 
in vitro and in vivo cases49, 50. However, irradiance effects have not been yet very clearly established in vitro in 
photobiomodulation. Although we might expect them in vivo, as light will be absorbed by skin chromophores 
(melanin, blood) and create bulk heat, it is less straightforward to expect irradiance effect in vitro. It might also 
have been that that our irradiance levels are not separated ‘well enough’ (only a factor 2 to 8 depending on the 
wavelength).
Third, we did not see any strong effect on the relative cell number after light treatment. However, the liter-
ature does contain evidence that short visible wavelengths exert anti-proliferative effects20, 49. The underlying 
reason of observed differences is that our biological model (low confluency, low serum and low oxygen) was tai-
lored to resemble in vivo conditions of the dermal fibroblasts, where their proliferative activity is very low under 
non-wounded conditions. Combined with the replenishment of the media after light treatment, we barely can 
notice any proliferation for the duration of the experiments with light. Therefore, we were not expecting to be able 
to detect an effect on the relative cell number after treatment with light.
We conclude that in vitro experimental design factors including cell confluency, serum concentration, culture 
conditions like oxygen level, impact cell behavior33, 51 and so are critical to how we best define cell reactions to 
light i.e., either inhibitory, neutral or stimulatory, even when responding to light of the identical characteristics. 
Therefore, we recommend that for all in vitro and ex vivo investigations on photobiomodulation researchers 
should not only carefully select their experimental conditions as close to the physiological in vivo setting as possi-
ble but in any event report these together with their experimental findings. The implications of our study findings 
are that we recommend that confluency, serum- and environmental oxygen concentration should ideally be much 
lower than those currently used and reported worldwide in conventional dermal fibroblast culture protocols.
Figure 7. Impact of blue (450 nm) and NIR (850 nm) light treatment on the metabolic activity of human 
dermal fibroblasts when exposed to dermal tissue oxygen levels (approx. 2%). (A) Fluorescence counts (Alamar 
Blue) measured in reticular and papillary fibroblasts (facelift, female, 64 yo) in low (2%) and high (20%) 
oxygen levels. No strong change in Alamar fluorescence count is apparent. (B) Relative cell counts of human 
dermal fibroblasts (reticular and papillary) after light treatment in hypoxic conditions (2% oxygen). Cells were 
grown in 35-mm individual dishes and treated with light once a day for three consecutive days. Cell counting 
was performed 24 h after last treatment. Material originating from two different donors was included in the 
experiment (N = 2, reticular and papillary, 3 repeats, 12 counts per bar). (C) Relative metabolic activity of 
human papillary fibroblasts in response to 30 J.cm−2 at 450 nm in low and high environmental oxygen levels 
(N = 2, papillary and 3 replicates). (D) Relative metabolic activity of human reticular fibroblasts in response to 
20 J.cm−2 at 850 nm in low and high environmental oxygen levels (N = 2, reticular and 3 replicates). Irradiance 
levels were 50 mW.cm−2 (450 nm) and 80 mW.cm−2 (850 nm).
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Experimental Procedure and Methods
Light-based devices. A proprietary LED-based device was designed to accommodate a single 24-well cul-
ture plate (Fig. 8) and had two sub-modules. Each module illuminated 4 rows of 6 wells. Each row of 6 wells was 
irradiated with the same wavelength. Rows of sub-module 1 were illuminated using 450, 500, 530 nm, while rows 
of sub-module 2 used 590, 655 and 850 nm light (Fig. 8A,B). Each sub-module had one row of wells without light 
treatment, which served as a control. Light leakage from well-to-well and thus light contamination was prevented 
by using blocking apertures between each individual LEDs (Fig. 8C) and by selecting black 24-well plate (Porvair 
Science, 303012).
The light beam under each well was created by a single LED (Lumileds LUXEON Rebel Color: Royal Blue 
450 nm LXML-PR01–0500, Cyan 500 nm LXML-PE01–0070, Green 530 nm LXML-PM01–0090, Amber 590 nm 
LXML-PL01–0040 and Deep Red 655 nm LXM3-PD01–0300; OSRAM OSLON Black Series SFH4715S 850 nm) 
(Fig. 8C). The homogeneity of the illumination in x-y plane under each individual well, measured using a camera 
was within ±15% of the average and was found to be acceptable (Fig. 8D). The exposure time and irradiance 
settings were controlled via a computer interface. Optical power at the level of the target, i.e., at the bottom 
of the well-plate, was measured using Ophir Nova II power meter (Ophir Photonics) equipped with detector 
(PD300–3W). Bottom-illumination of the well-plate avoided unnecessary absorption of light by the support of 
the module and any potential increase in temperature, both of which can be a problem in case of top-based 
illumination.
Primary human dermal fibroblast isolation and culture. Human dermal fibroblasts were isolated 
from fresh surplus residual human facial skin within 8 hours of surgery. Human skin was obtained after facelift 
surgery from healthy donors adhering to the Declaration of Helsinki principles under Human Tissue Transfer 
Agreement, between Philips Electronics Nederland B.V. acting through Philips Research and corresponding 
clinics, where clinics were responsible for having a full written informed consent from all patients. All experi-
mental protocols were approved by the Philips Internal Committee of Biomedical Experiments (ICBE). Philips 
Electronics Nederland B.V., acting through Philips Research Eindhoven, confirms that it was its responsibility to 
ensure that approvals by appropriate local and/or national Ethics Committees and relevant authorizations were 
obtained whenever such approvals were required for the experiment(s).
Figure 8. LED-based devices used in the experiments. (A) Photograph of sub-module 1 with the LEDs 
emitting 450, 500 and 530 nm wavelengths and (B) sub-module 2 with the LEDs emitting 590, 655 and 850 nm 
wavelengths. (C) Cross-section of the design a module, in the direction of a row of 6 wells of the 24-well plate 
(D) Typical profile of one single light beam in the axial x-y direction (at 450 nm) under one of the wells of the 
24-well plate (the size of 1 well is 15 mm diameter) measured using a standard camera.
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Papillary and reticular fibroblasts lineages were extracted from superficial and deep dermis, respectively. Cells 
were initially cultured in DMEM supplemented with penicillin/streptomycin (1%), Glutamax (1%) and fetal 
bovine serum (FBS) (at 10%). The concentration of FBS was later very gradually reduced to 2% to quiesce fibro-
blast proliferation but not metabolic activity.
Pairs of reticular and papillary were donor sample-matched, unless otherwise indicated. The total number 
of donor used in the experiments was 4, the age of the donors was between 47 to 64 years old, the gender of the 
samples included both male and female and the passage was kept between passage 4 and 8 for all experiments.
Light treatment protocols. The cells were treated daily over 3 consecutive days, during which the culture 
medium was refreshed after each light treatment, unless stated. Light treatment was conducted outside the culture 
incubator but never extended beyond a maximum of 20 minutes at room temperature. Any increase in tempera-
ture of the cell substratum due to the light treatment was assessed using a FLIR infrared camera (SC600). Thermal 
increase never exceeded 37 °C (i.e., body and culture incubator temperature) for all tested wavelengths and at all 
treatment time intervals. We observed very slight heating, originating from the light treatment (maximum of 2oC 
at 530 nm and 850 nm). This increase did not correlate with the effects that we observed on the fibroblast meta-
bolic activity. Additionally, as treatment is done outside the incubator, the temperature of cells never exceeded the 
physiological range of skin temperature46. In a typical experiment the same 24-well plate contained both control 
and treated groups, as one row of the 24-well plate was always kept as control, i.e. not irradiated. This helped 
to control for any effect due to the treatment being performed outside the incubator. Indeed, both control and 
treated groups were always under the same ambient conditions. Light treatment was performed using transparent 
DMEM medium without phenol red (Sigma, D5921).
To assess any potential indirect impact of light on dermal fibroblasts via possible interactions with irradi-
ated DMEM culture medium components, a cell-free DMEM medium was similarly irradiated using the same 
wavelengths and doses of light and immediately brought in contact with the test cells. The time of cell ‘exposure’ 
to light-irradiated cell-free medium was equal to that of treatment when light was applied directly on the cells.
Measurement of dermal fibroblast metabolic activity. The metabolic activity of the dermal fibro-
blasts was assessed using the Alamar Blue® assay52 (Thermofisher, DAL1100). It was chosen for reported smallest 
variability across the different cell lineages, compared to MTT assay, often considered as the gold standard for 
determination of cell viability and proliferation53. MTT assay measures cell viability in terms of reductive activity 
as enzymatic conversion of the tetrazolium compound to water insoluble formazan crystals by dehydrogenases 
occurring in the mitochondria of living cells although reducing agents and enzymes located in other organelles 
such as the endoplasmic reticulum are also involved.
In contrast to MTT assay, in Alamar Blue® kit, the conversion of active component, resazurin, to fluorescent 
resorufin occurs mostly in the mitochondria and the quantity of resorufin generated can therefore be used as 
indicator of metabolic activity54.
On the day of assessment Alamar Blue® was added to fresh DMEM (10% in volume). The solution was then 
incubated in contact with the cells for 3 to 5 hours depending on the confluency of cells. The fluorescence gen-
erated was read using a plate reader FLUOstar Omega II (ex: 544 nm, em: 590 nm). The experimental outcome 
of the light-based treatments was expressed in terms of relative metabolic activity, defined as a ratio between the 
means of the treated groups and the control group.
Assessment of viability and cell number. Automatic cell counting, Vi-CELL XR (Beckman Coulter Life 
Sciences), was used to assess the cell number. Cells were grown in 35-mm individual dishes and treated with light 
once a day for three consecutive days. The cells were counted 24 h after the last treatment. For each condition, 
the cells of 3 individual dishes were pooled together before counting. Cells counting was repeated three times. 
Material originating from two donors was included in the experiment (N = 2, reticular and papillary, 3 repeats, 12 
counts per bar). Trypan blue is automatically added to assess viability as well.
Assessment of cell morphology. Conventional phase-contrast light microscopy (Leica DMIL LED, obj. 
x10) was used daily to assess the morphological change of the dermal fibroblasts along treatment duration of 
three days.
Design of experiment and statistical analysis. Previously, we described the statistical approach for a 
systematic assessment of the impact of optical and biological factors on the response of human dermal fibroblasts 
to light24. It is based on a factorial design of experiment, allowing identification of the factors having a significant 
impact on the variation of a variable under investigation, i.e., Alamar Blue® reading in case of this study. Such 
factors span a multidimensional space and are related to light treatment (i.e., optical variables) and the target 
and its environment (biological variables). Optical variables included: wavelength (nm), irradiance (mW.cm−2), 
radiant exposure or dose (J.cm−2), and biological variables included: serum concentration (% FBS), confluency 
(cells per units of surface), oxygen level (%) and treatment protocols (with or without replenishment of media 
after treatment, treatment with irradiated cell-free media).
Each factor was then varied among pre-defined levels, in our case – this was equal to 2, except for wavelength 
(where 6 discrete wavelengths were used). The level intervals were chosen to be large enough to show its impact, 
if present, on the variable of interest. The selected levels of the optical parameters are given in Table 1, while the 
levels of the biological factors are given in the Results section.
The pre-defined factors were then varied within the same experiment in a full factorial design mode. This 
allowed for a fair estimation of the effect of each factor independently, as well as any interaction between them. As 
a consequence, the number of experiments to be performed is equal to the number of levels to the power of the 
number of factors. This provided statistical power when assessing the effect of one single factor on the variation 
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of our readout, as the variation of the response due to each of its level is weighted by the same combinations of all 
the other factors and levels. The resulting variation is therefore most probably due to the variation of this single 
factor itself.
Visually two representations for data were used, namely the main effects plot and the interaction plot. While 
the first shows the effects of each factor separately, the second one shows the interaction between the factors and 
how it impacts the variable of interest, i.e., metabolic activity. The numerical analysis is performed using ANOVA. 
When indicated, a Student’s t-test was used to compare two different conditions.
Our measurement method and setup were analyzed through a gage R&R approach. Operator, measuring 
instrument and method (plate reader, etc.), microplate type (black/white), illumination system and technical 
repeatability were tested. The results of the ANOVA analysis directly determined our selection of parameter and 
method to reduce the variability and reach satisfying level of reproducibility and repeatability55.
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